What the MCCQE tests in respirology
The MCC Examination Objectives frame respirology as presentations: dyspnea, cough, wheezing, hemoptysis, chest pain, abnormal chest imaging, hypoxia and sleep problems. Questions start with a patient who has one of these and ask you to sort out the cause, choose the test that will change management, or pick the treatment that fits a Canadian guideline.
All four dimensions of care appear. Health promotion and illness prevention covers smoking cessation, vaccination, lung cancer screening and occupational exposures. Acute care covers asthma and COPD exacerbations, pneumonia, pulmonary embolism, pneumothorax and massive hemoptysis. Chronic care covers long-term asthma and COPD control, interstitial lung disease and sleep apnea. Psychosocial items include inhaler technique and adherence, fitness to drive with untreated sleep apnea, and goals-of-care discussions in end-stage lung disease.
The physician activities most often tested are assessment and diagnosis (interpreting spirometry, blood gases, pleural fluid, imaging) and management (stepping therapy up or down, choosing a site of care, deciding on anticoagulation). Communication questions often involve explaining a new inhaler, counselling on smoking, or discussing a lung nodule that needs follow-up.
- Spirometry, arterial blood gases and pleural fluid are tested as data you must interpret, not just order
- Severity scoring decides the site of care: home, ward or intensive care
- Prevention items often hinge on Canadian screening ages and criteria
- Communication items test inhaler teaching, smoking cessation and breaking news about a nodule or cancer
Asthma and COPD: the Canadian Thoracic Society approach
Asthma is diagnosed with objective testing, not symptoms alone. Spirometry showing airflow obstruction that improves after a bronchodilator (an FEV1 increase of at least 12% and 200 mL) supports the diagnosis. If spirometry is normal but the story is typical, a methacholine challenge or other test of airway hyperresponsiveness helps. Questions like to test this step: a patient labelled as having asthma who has never had spirometry should have it before therapy is escalated.
Canadian Thoracic Society guidance moved away from treating asthma with a short-acting bronchodilator alone. Every patient with asthma should have inhaled corticosteroid-containing therapy. For mild asthma in people aged 12 and older, as-needed budesonide-formoterol or regular low-dose inhaled corticosteroid are both options. Long-acting beta-agonist monotherapy is never correct in asthma. Before stepping up, check inhaler technique, adherence, triggers and alternative diagnoses. Poor control signs include daytime symptoms or reliever use more than a couple of times a week, night waking, activity limitation and any exacerbation needing oral steroids.
For acute asthma, give salbutamol, ipratropium in moderate to severe attacks, systemic corticosteroids and oxygen to correct hypoxia. IV magnesium is added for severe attacks. A silent chest, exhaustion, confusion, or a normal or rising PaCO2 in a breathless patient are signs of impending respiratory failure.
COPD is confirmed by post-bronchodilator spirometry showing a fixed reduced FEV1/FVC ratio. Management in CTS guidance is built on symptoms and exacerbation risk. Smoking cessation, vaccination, an action plan, exercise and pulmonary rehabilitation apply to everyone. For patients with significant symptoms, dual long-acting bronchodilator therapy (LAMA/LABA) is favoured; triple therapy with an inhaled corticosteroid is added for patients who keep having exacerbations. Inhaled corticosteroid alone is not COPD treatment. Long-term oxygen improves survival only in patients with chronic resting hypoxemia (PaO2 of 55 mm Hg or less, or up to 60 mm Hg with cor pulmonale or polycythemia).
- Asthma: no SABA-only treatment; every patient needs an inhaled corticosteroid-containing regimen
- Asthma: never LABA without an inhaled corticosteroid
- COPD exacerbation: bronchodilators, a short course of oral corticosteroid, antibiotics when sputum becomes purulent
- COPD with hypercapnia: target SpO2 88-92% and use non-invasive ventilation for respiratory acidosis
Pneumonia and pulmonary embolism
For community-acquired pneumonia, the exam tests diagnosis (chest X-ray to confirm), severity and site of care, and empiric antibiotics. CURB-65 (confusion, urea, respiratory rate, blood pressure, age 65 or older) is a quick severity tool; clinical judgement, oxygen needs, comorbidities and social situation also matter. A previously healthy outpatient can be treated with a single oral agent such as amoxicillin, doxycycline or a macrolide, chosen with local resistance in mind. Patients with significant comorbidities or recent antibiotics need broader coverage, and admitted patients need IV therapy. Aspiration risk, recent hospitalization and immunosuppression change the likely organisms.
Do not forget tuberculosis in pneumonia that is slow to resolve, upper-lobe or cavitary disease, weight loss and night sweats, especially in people born in high-incidence countries, people who have lived in some First Nations and Inuit communities, and people with HIV. The correct step is airborne isolation and sputum for acid-fast bacilli, and TB is reportable to public health.
For suspected pulmonary embolism, the exam tests structured probability. Estimate pretest probability with the Wells score. If probability is low, apply the PERC rule: a patient who meets all eight criteria needs no testing. If PERC is not met, or probability is intermediate, measure a D-dimer; age-adjusted cut-offs reduce unnecessary imaging in patients older than 50. A positive D-dimer or high probability leads to CT pulmonary angiography, or a ventilation-perfusion scan when contrast is a problem. Unstable patients cannot go to CT: bedside echocardiography showing right ventricular strain supports treatment.
Most stable patients with PE can be treated with a DOAC, often as outpatients if risk is low. Systemic thrombolysis is reserved for PE with hypotension (high-risk or massive PE) without major contraindications. In pregnancy, low molecular weight heparin is used. Treatment length depends on whether the clot was provoked by a major transient factor (usually 3 months) or unprovoked (consider extended therapy if bleeding risk allows).
- Wells low plus PERC negative: no D-dimer, no imaging
- Contrast allergy, renal impairment or pregnancy: consider a V/Q scan or compression ultrasound first if leg symptoms are present
- PE with shock: thrombolysis, not just anticoagulation
- Pneumonia in an older smoker: arrange follow-up imaging to exclude an underlying cancer if symptoms persist
Suspected pulmonary embolism: the testing pathway
- 1Check stability firstHypotension or shock: bedside echo for right ventricular strain and treat; do not send an unstable patient to CT.
- 2Estimate pretest probabilityUse the Wells score from the details in the stem: heart rate, leg signs, prior VTE, surgery, cancer, hemoptysis, alternative diagnosis.
- 3Low probability: apply PERCIf all eight PERC criteria are met, stop. No D-dimer and no imaging are needed.
- 4PERC fails or intermediate: D-dimerUse an age-adjusted cut-off over age 50. A negative result rules out PE in low or intermediate probability.
- 5High probability or positive D-dimerCT pulmonary angiography; V/Q scan when contrast is a problem or in pregnancy after leg ultrasound if leg symptoms.
- 6Treat by riskDOAC for most stable patients, LMWH in pregnancy, thrombolysis for PE with hypotension; set duration by provoked or unprovoked.
Pleural effusion, interstitial lung disease and hemoptysis
Pleural effusion questions usually give you fluid results and ask what they mean. Light's criteria identify an exudate when any one is met: pleural to serum protein ratio above 0.5, pleural to serum LDH ratio above 0.6, or pleural LDH above two thirds of the upper limit of normal for serum. Transudates point to heart failure, cirrhosis or nephrotic syndrome; treat the cause and avoid repeated taps. Exudates point to infection, cancer, tuberculosis, pulmonary embolism or autoimmune disease.
In a parapneumonic effusion, pleural pH below 7.2, low glucose, frank pus or organisms on Gram stain or culture mean a complicated effusion or empyema that needs chest tube drainage plus antibiotics. Antibiotics alone will not clear it. A lymphocytic exudate in a patient from a high-incidence country should raise tuberculous pleuritis. A recurrent malignant effusion is managed with an indwelling pleural catheter or pleurodesis.
Interstitial lung disease presents with progressive exertional dyspnea, dry cough, fine bibasal crackles and sometimes clubbing. The exam tests the search for a cause: occupational and environmental exposures (asbestos, silica, birds, mouldy hay), drugs (amiodarone, methotrexate, nitrofurantoin, some chemotherapy) and connective tissue disease. High-resolution CT is the key test. Idiopathic pulmonary fibrosis is a diagnosis of exclusion in older adults and is treated with antifibrotic drugs; steroids are not the answer for IPF. Sarcoidosis with bilateral hilar lymphadenopathy and erythema nodosum often needs no treatment at first.
Hemoptysis questions split into small-volume and massive bleeding. For massive hemoptysis, protect the airway, place the patient with the bleeding side down, reverse anticoagulation, and arrange CT angiography and bronchoscopy, with bronchial artery embolization as the usual definitive step. For smaller amounts, the work-up depends on risk: bronchitis is common, but an older smoker with hemoptysis needs imaging for cancer, and TB, bronchiectasis, pulmonary embolism, mitral stenosis and vasculitis with kidney involvement stay on the list.
- Exudate by Light's criteria: find the cause; transudate: treat the underlying condition
- Pleural pH below 7.2 in a parapneumonic effusion: chest tube
- Ask about drugs and occupation in every interstitial lung disease stem
- Hemoptysis with red cell casts or hematuria: think of a pulmonary-renal syndrome
Pneumothorax and acute respiratory failure
Pneumothorax questions test three decisions: is it under tension, is it primary or secondary, and is the patient stable. Tension pneumothorax is a clinical diagnosis. Hypotension, distended neck veins, absent breath sounds on one side and rising airway pressures in a ventilated patient mean you decompress first and image later. Needle decompression is followed by a chest tube. An answer that orders a chest X-ray before decompression in a crashing patient is a trap.
A primary spontaneous pneumothorax happens in a young, usually tall, thin smoker with no lung disease. If the patient is stable and the pneumothorax is small, observation with follow-up imaging is reasonable. A larger or symptomatic primary pneumothorax is treated with needle aspiration or a small-bore chest tube. A secondary pneumothorax, in a patient with COPD, cystic fibrosis or another lung disease, is more dangerous because the reserve is lower: these patients are usually admitted and most need a chest tube. Smoking cessation and advice about air travel and diving belong in the counselling part of the answer.
Acute respiratory failure splits into two types. Hypoxemic failure (low PaO2 with normal or low PaCO2) comes from pneumonia, pulmonary edema, ARDS, pulmonary embolism and atelectasis. Hypercapnic failure (high PaCO2 with acidosis) comes from COPD, severe asthma, neuromuscular weakness, chest wall disease and drugs that depress breathing, such as opioids. The type tells you the support: oxygen and treatment of the cause for hypoxemic failure, ventilation (non-invasive first when appropriate) for hypercapnic failure. A patient who cannot protect the airway, is vomiting or is not cooperating is not a candidate for non-invasive ventilation and needs intubation.
- Tension pneumothorax: decompress before imaging
- Secondary pneumothorax in COPD: admit, usually chest tube
- Hypercapnic failure with acidosis in COPD: non-invasive ventilation if the patient can protect the airway
- Opioid-induced hypoventilation: naloxone and airway support, not just oxygen
Lung cancer screening, nodules and sleep apnea
The Canadian Task Force on Preventive Health Care recommends screening with low-dose CT for adults aged 55 to 74 with at least a 30 pack-year smoking history who smoke now or quit less than 15 years ago, once a year for up to three consecutive years, in settings with access to expert care. Chest X-ray and sputum cytology are not screening tests. Provincial programs may use risk-prediction models and slightly different rules, so check your province, but for exam purposes know the CTFPHC criteria and how they differ from US rules.
For a lung nodule found by chance, the first step is to compare with any previous imaging. A solid nodule that has not grown over two years is generally benign. Otherwise, follow-up depends on size, appearance (solid, part-solid or ground-glass) and patient risk, using a recognized protocol. Larger or growing nodules, spiculated edges and upper-lobe location in a smoker raise the probability of cancer and lead to PET-CT, biopsy or surgical referral. Communication questions ask how to explain uncertainty and arrange follow-up so the patient is not lost.
Obstructive sleep apnea presents with loud snoring, witnessed apneas, unrefreshing sleep and daytime sleepiness, often with obesity, hypertension, atrial fibrillation or a large neck. Questionnaires such as STOP-Bang help screening. Diagnosis is by polysomnography or a home sleep apnea test in suitable patients. CPAP is first-line for moderate to severe disease, with weight loss, alcohol reduction and positional measures as supports. Canadian guidance on fitness to drive with sleep apnea matters: a sleepy commercial driver is a classic professional-behaviour question.
- CTFPHC screening: age 55-74, 30 or more pack-years, current or quit under 15 years, up to 3 annual low-dose CTs
- Stable solid nodule over 2 years: generally benign
- Untreated sleep apnea with daytime sleepiness: address driving safety
- Smoking cessation advice at every visit; varenicline and combination nicotine replacement are effective options
Canadian practice points and differences from US practice
Lung cancer screening is the clearest difference. The US Preventive Services Task Force screens from age 50 to 80 with a 20 pack-year history, every year. The CTFPHC uses age 55 to 74, a 30 pack-year history and up to three annual scans. If the stem gives a 52-year-old with a 25 pack-year history and asks about screening in Canada, the CTFPHC answer is that screening is not recommended under its criteria.
For asthma and COPD, the exam follows Canadian Thoracic Society guidance. It aligns broadly with international reports but has Canadian specifics, such as clear advice against SABA-only treatment and the use of as-needed budesonide-formoterol in mild asthma. Drug names follow Canadian use: salbutamol rather than albuterol. Blood gas pressures are reported in mm Hg, while other lab values are in SI units (urea and glucose in mmol/L, D-dimer in micrograms per litre).
Tuberculosis is more central in Canada than many candidates expect. Know the Canadian Tuberculosis Standards basics: screening for latent infection in people at higher risk (recent contacts, some immigrants from high-incidence countries, people starting immunosuppression), the use of interferon-gamma release assays in people with past BCG vaccination, airborne isolation for suspected active disease, and mandatory public health reporting. Vaccination advice (influenza, pneumococcal, COVID-19 and RSV for eligible older adults) follows NACI and the Canadian Immunization Guide.
Choosing Wisely Canada advises against antibiotics for acute bronchitis in otherwise healthy adults, against routine pre-operative chest X-rays in low-risk patients, and against CT pulmonary angiography when a low-probability patient has a negative D-dimer or is PERC negative. These recommendations often decide between two plausible answers.
- Lung screening: CTFPHC 55-74 and 30 pack-years, not the US 50-80 and 20 pack-years
- Salbutamol, not albuterol
- No antibiotics for uncomplicated acute bronchitis
- TB is reportable; isolate first, then test
Canadian answers versus common US habits in respirology
Canadian practice (MCCQE answer)
- Lung screening at 55-74 with 30+ pack-years, up to 3 annual low-dose CTs (CTFPHC)
- Salbutamol named as the short-acting reliever
- No SABA-only treatment; ICS-containing therapy for all asthma (CTS)
- Lab values in SI units: urea and glucose in mmol/L
- TB screening and reporting under the Canadian Tuberculosis Standards
Common US or other-system habit
- Screening from 50 to 80 with 20+ pack-years every year (USPSTF)
- Albuterol named as the short-acting reliever
- Older step 1 teaching of reliever-only treatment for mild asthma
- Lab values in conventional (non-SI) units
- TB guidance from US agencies with different screening groups
How to read MCCQE respirology stems
Look at oxygen saturation, respiratory rate and mental status before anything else. A drowsy patient with COPD and a high PaCO2 is a ventilation question, not a diagnosis question. A patient with asthma who has stopped wheezing but looks exhausted is getting worse, not better.
Read the blood gas in order: pH, PaCO2, bicarbonate, then oxygenation. Acute respiratory acidosis has a low pH with a high PaCO2 and little rise in bicarbonate; chronic retention has a near-normal pH with raised bicarbonate. An A-a gradient helps decide whether hypoxemia comes from hypoventilation alone or from lung disease.
In pulmonary embolism stems, note every Wells and PERC item the writer gives you: age, heart rate, saturation, estrogen use, prior VTE, recent surgery, leg swelling, hemoptysis. The answer depends on whether each criterion is met. In pleural stems, calculate the ratios yourself rather than guessing from one number.
Finally, watch for exposure and travel clues. Country of birth, occupation, birds at home, injection drug use and recent travel are rarely decoration. They usually point to TB, hypersensitivity pneumonitis, occupational lung disease or septic emboli.
- Vitals and mental status decide whether you stabilize or investigate
- Interpret gases step by step, including compensation
- Score Wells and PERC from the stem before reading options
- Exposure history is usually the key to interstitial and infectious stems
Respiratory red flags that change the answer
Worked interpretation: spirometry, lung volumes and blood gases
Spirometry questions follow a fixed order. First, look at the FEV1/FVC ratio. A reduced ratio means obstruction. Then look at the bronchodilator response: significant reversibility supports asthma, while a fixed reduction after bronchodilator supports COPD. A normal or raised ratio with a low FVC suggests restriction, but spirometry cannot confirm it: you need total lung capacity from full lung volumes. Diffusing capacity (DLCO) separates the causes. It is low in emphysema and interstitial lung disease, usually normal in asthma, normal in restriction caused by obesity or chest wall disease, and can be raised in alveolar hemorrhage.
For blood gases, take the same five steps every time. Is the pH acidotic or alkalotic? Is the PaCO2 moving in the direction that explains it (respiratory) or not (metabolic)? Is the bicarbonate change appropriate for an acute or a chronic process? Is there a second disorder? What is the oxygenation and the A-a gradient? In acute respiratory acidosis the bicarbonate rises only slightly, about 1 mmol/L for every 10 mm Hg rise in PaCO2. In chronic retention, renal compensation raises bicarbonate by roughly 3 to 4 mmol/L per 10 mm Hg, so the pH is near normal.
Worked example: a patient with COPD has pH 7.28, PaCO2 70 mm Hg and bicarbonate 32 mmol/L. The pH is acidotic and the PaCO2 is high, so the primary problem is respiratory. A bicarbonate of 32 is higher than an acute rise would give, so this is acute-on-chronic hypercapnia: a known retainer who has decompensated. The exam answer is controlled oxygen and non-invasive ventilation, not high-flow oxygen.
The A-a gradient answers a different question: is the low oxygen explained by hypoventilation alone? On room air at sea level, alveolar oxygen is roughly 150 minus PaCO2 divided by 0.8. A normal gradient with low PaO2 points to hypoventilation (sedation, neuromuscular disease). A wide gradient points to lung disease: ventilation-perfusion mismatch, shunt or a diffusion problem. A hypoxemic patient whose saturation hardly improves with high-flow oxygen has a shunt, as in ARDS or dense consolidation.
- Low FEV1/FVC: obstruction; then check reversibility
- Low FVC with normal ratio: confirm restriction with total lung capacity
- Low DLCO: emphysema or interstitial disease; normal DLCO: asthma or extrapulmonary restriction
- High PaCO2 with high bicarbonate and near-normal pH: chronic retention
- Normal A-a gradient with hypoxemia: hypoventilation
How the MCCQE frames respirology: three mini cases
Case one is a prevention item. A 60-year-old woman who smoked a pack a day for 35 years and quit eight years ago asks whether she needs a chest X-ray to check for cancer. The tested decision is not the X-ray. She meets the CTFPHC criteria for low-dose CT screening, and the strongest answer explains the benefits, false positives and incidental findings, then offers referral to an organized program where one exists. The distractors will include chest X-ray, sputum cytology and no screening because she has quit.
Case two is a management item set in the emergency department. A 70-year-old man with COPD is drowsy after receiving high-flow oxygen by mask in the ambulance. His gas shows a worsening respiratory acidosis. The question asks for the next step. The writer wants you to recognize oxygen-induced hypercapnia, reduce the oxygen to a target saturation of 88 to 92%, start non-invasive ventilation and treat the exacerbation with bronchodilators and systemic corticosteroid. Intubation is correct only if he cannot protect his airway or fails a trial of non-invasive ventilation.
Case three is a communication and professionalism item. A long-haul truck driver has loud snoring, witnessed apneas and has nodded off at the wheel. He asks you not to write anything down because he will lose his job. The exam tests your duty: you arrange a sleep study and treatment, advise him not to drive commercially until his sleepiness is treated, and follow your province's rules on reporting medically unfit drivers, which are mandatory in some provinces and discretionary in others. Keeping it off the chart is never the answer.
- Prevention stems test eligibility and shared decision-making, not only the test name
- Emergency stems test the first safe step before the full work-up
- Professional stems test documentation, safety of others and provincial reporting rules
Respirology in NAC stations and communication tasks
Many NAC stations use a respiratory presentation because it combines history, a focused examination and counselling. Common tasks include a focused history for chronic cough, shortness of breath or hemoptysis; a narrated chest examination; teaching inhaler technique; smoking cessation counselling; and explaining a new diagnosis such as COPD or a lung nodule that needs follow-up.
For a chronic cough or dyspnea history, cover onset and tempo, triggers, sputum and blood, fever, weight loss and night sweats, orthopnea and leg swelling, smoking in pack-years, vaping, occupational and home exposures, travel and country of birth, TB contacts, medications (an ACE inhibitor can cause cough) and functional impact. Narrate the examination in a logical order: general look and vital signs, hands (clubbing, tar staining, asterixis), neck veins and trachea, then inspection, palpation, percussion and auscultation of the chest from front and back.
Smoking cessation counselling works best with a simple structure: ask about smoking at every visit, advise quitting clearly and personally, assess readiness, assist with a plan and medication (combination nicotine replacement, varenicline or bupropion), and arrange follow-up. Offer provincial quit-line support. In a patient who is not ready, a brief motivational conversation and an open door earns marks; lecturing does not.
Inhaler teaching stations reward checking technique by watching, not by asking. Ask the patient to show you, correct one step at a time, and use teach-back. Explain the difference between a reliever and a controller, and give a written action plan for asthma that says what to do when symptoms worsen. End-stage COPD stations may test goals-of-care conversations: explore the patient's values, discuss what ventilation and ICU admission would involve, and document the plan.
- History: smoking in pack-years, exposures, TB risk, ACE inhibitor use
- Exam: narrate inspection, palpation, percussion, auscultation in order
- Counselling: ask, advise, assess, assist, arrange
- Inhalers: watch, correct, teach back, written action plan
A one-week respirology revision plan
If you have a week before you move on, spread the work so each day has one theme, a short set of practice questions and a review of every option you got wrong. Keep a page of personal errors; it is more useful than rereading notes.
Day one covers asthma and COPD diagnosis and step-up therapy, ending with ten questions. Day two covers exacerbations, oxygen targets and non-invasive ventilation, with ten blood gases worked by hand. Day three covers pneumonia, tuberculosis and Canadian vaccination advice. Day four covers pulmonary embolism decision rules and anticoagulation. Day five covers pleural fluid, interstitial disease and hemoptysis. Day six covers screening, nodules, sleep apnea and smoking cessation, plus a practice NAC-style counselling script said out loud. Day seven is a timed mixed block of respirology and cardiology questions, because dyspnea stems often hide heart failure or PE.
- One theme per day, ten to twenty questions per day
- Hand-work every blood gas and pleural ratio
- Finish with a mixed timed block that blends respiratory and cardiac causes of dyspnea
| Scenario | Key clue in the stem | Most likely answer |
|---|---|---|
| Mild asthma on salbutamol only | Reliever use a few times a week | Start an ICS-containing regimen (e.g. as-needed budesonide-formoterol) |
| Severe acute asthma | Silent chest, rising PaCO2, exhaustion | ICU review, IV magnesium, prepare for ventilation |
| COPD exacerbation with acidosis | pH below 7.35, high PaCO2 | Non-invasive ventilation, controlled oxygen |
| Low-risk chest pain, possible PE | Wells low, all PERC criteria met | No further testing |
| PE with hypotension | Right ventricular strain on bedside echo | Systemic thrombolysis |
| Parapneumonic effusion | Pleural pH below 7.2 or pus | Chest tube drainage plus antibiotics |
| Cavitary upper-lobe lesion | Weight loss, born in a high-TB country | Airborne isolation and sputum for AFB |
| Massive hemoptysis | Large-volume bleeding, falling saturation | Airway, bleeding side down, CT angiography, embolization |
| Heavy smoker asking about screening | Age 55-74, 30 or more pack-years | Low-dose CT annually for up to 3 years |
| Sleepy truck driver who snores | Witnessed apneas, hypertension | Sleep study and driving safety advice |
Worked examples in MCCQE style
Pick an answer to see why each option is right or wrong. These examples are written for this page; the bank holds the full set for respirology.
Example 1
A 23-year-old woman comes to a walk-in clinic for an inhaler refill. Asthma was confirmed by spirometry two years ago. She uses salbutamol 2 to 3 times a week for wheeze with exercise and cold air. She does not wake at night and has never needed oral steroids or an emergency visit. Her inhaler technique is good. She takes no other medications. Examination is normal.
Which change to her treatment is most appropriate?
-
Canadian Thoracic Society guidance recommends inhaled corticosteroid-containing therapy for all patients with asthma. For mild asthma in people aged 12 and older, as-needed budesonide-formoterol is an accepted option.
-
Leukotriene receptor antagonists are less effective than inhaled corticosteroids and are not the preferred controller in mild asthma.
-
SABA-only treatment is no longer recommended because it is linked to more severe exacerbations and asthma deaths.
-
LABA monotherapy without an inhaled corticosteroid increases the risk of severe asthma events and is never appropriate.
-
She is not having an exacerbation, so a course of oral steroid is not indicated.
Show answer and reasoning
Answer: A. As-needed budesonide-formoterol
- A. Canadian Thoracic Society guidance recommends inhaled corticosteroid-containing therapy for all patients with asthma. For mild asthma in people aged 12 and older, as-needed budesonide-formoterol is an accepted option.
- B. Leukotriene receptor antagonists are less effective than inhaled corticosteroids and are not the preferred controller in mild asthma.
- C. SABA-only treatment is no longer recommended because it is linked to more severe exacerbations and asthma deaths.
- D. LABA monotherapy without an inhaled corticosteroid increases the risk of severe asthma events and is never appropriate.
- E. She is not having an exacerbation, so a course of oral steroid is not indicated.
No patient with asthma should be managed on a short-acting reliever alone; mild asthma still needs an ICS-containing regimen.
Based on: Canadian Thoracic Society asthma guideline update
Example 2
A 38-year-old woman presents to the emergency department with two days of sharp right-sided chest pain that is worse on deep breathing, starting after a 6-hour flight. She takes a combined oral contraceptive. Heart rate 92/min, blood pressure 122/76 mm Hg, respiratory rate 18/min, SpO2 97% on room air. No leg swelling, no hemoptysis and no prior VTE. Chest X-ray and ECG are normal. The physician judges PE less likely than musculoskeletal pain.
What is the most appropriate next step?
-
Imaging first is not needed when pretest probability is low. A negative D-dimer would avoid radiation and contrast.
-
Empiric anticoagulation is for patients with high probability or a delay to testing, which is not the case here.
-
A V/Q scan is an imaging option when CT is unsuitable, but imaging is not the next step at low probability.
-
PERC cannot be applied to rule out PE because she uses estrogen, which fails one of the eight criteria.
-
Her Wells score puts her at low probability, but she fails PERC because of estrogen use. A D-dimer is the next step, and a negative result rules out PE.
Show answer and reasoning
Answer: E. Measure a D-dimer level
- A. Imaging first is not needed when pretest probability is low. A negative D-dimer would avoid radiation and contrast.
- B. Empiric anticoagulation is for patients with high probability or a delay to testing, which is not the case here.
- C. A V/Q scan is an imaging option when CT is unsuitable, but imaging is not the next step at low probability.
- D. PERC cannot be applied to rule out PE because she uses estrogen, which fails one of the eight criteria.
- E. Her Wells score puts her at low probability, but she fails PERC because of estrogen use. A D-dimer is the next step, and a negative result rules out PE.
Low probability plus any failed PERC criterion means D-dimer next, not imaging and not discharge.
Based on: Wells and PERC clinical decision rules; Thrombosis Canada clinical guides
Example 3
A 61-year-old man admitted with right lower lobe pneumonia has had fever for 4 days despite IV ceftriaxone and azithromycin. Temperature 38.7 C, heart rate 104/min, SpO2 94% on 2 L/min. Chest X-ray shows a moderate right pleural effusion. Diagnostic thoracentesis gives cloudy fluid with pH 7.05, glucose 1.8 mmol/L and LDH well above the serum value. Gram stain shows no organisms.
What is the most appropriate next step?
-
Ongoing fever with a complicated effusion will not settle with antibiotics alone; waiting a week risks a loculated empyema.
-
Broadening antibiotics without draining infected fluid does not treat the source.
-
Repeat sampling adds no new information. The fluid already meets criteria for drainage.
-
Pleural pH below 7.2 and low glucose define a complicated parapneumonic effusion. It needs chest tube drainage together with antibiotics.
-
Surgery is for loculated empyema that fails tube drainage (with or without intrapleural fibrinolytic therapy), not the first step.
Show answer and reasoning
Answer: D. Chest tube drainage plus antibiotics
- A. Ongoing fever with a complicated effusion will not settle with antibiotics alone; waiting a week risks a loculated empyema.
- B. Broadening antibiotics without draining infected fluid does not treat the source.
- C. Repeat sampling adds no new information. The fluid already meets criteria for drainage.
- D. Pleural pH below 7.2 and low glucose define a complicated parapneumonic effusion. It needs chest tube drainage together with antibiotics.
- E. Surgery is for loculated empyema that fails tube drainage (with or without intrapleural fibrinolytic therapy), not the first step.
In a parapneumonic effusion, pH below 7.2, low glucose, pus or positive Gram stain means drain it.
Based on: Light's criteria; Canadian Thoracic Society and international pleural disease guidance
Example 4
A 68-year-old man with known COPD is brought to the emergency department with three days of increased dyspnea and purulent sputum. The paramedics gave oxygen by non-rebreather mask. He is drowsy but rouses to voice and is protecting his airway. Respiratory rate 28/min, SpO2 99%, blood pressure 138/82 mm Hg. Arterial gas: pH 7.27, PaCO2 74 mm Hg, PaO2 118 mm Hg, bicarbonate 33 mmol/L.
In addition to bronchodilators and systemic corticosteroid, what is the most appropriate next step?
-
Excess oxygen in a CO2 retainer worsens hypercapnia. His saturation of 99% is above the target.
-
He is rousable and protecting his airway, so a trial of non-invasive ventilation comes first; intubation is for failure or an unprotected airway.
-
Acute-on-chronic hypercapnic acidosis in a COPD exacerbation is treated with oxygen titrated to SpO2 88-92% and non-invasive ventilation.
-
The acidosis is respiratory. Bicarbonate does not fix ventilation and can worsen CO2 retention.
-
Nothing in the stem suggests opioid use. Drowsiness here is from CO2 retention.
Show answer and reasoning
Answer: C. Titrated oxygen and non-invasive ventilation
- A. Excess oxygen in a CO2 retainer worsens hypercapnia. His saturation of 99% is above the target.
- B. He is rousable and protecting his airway, so a trial of non-invasive ventilation comes first; intubation is for failure or an unprotected airway.
- C. Acute-on-chronic hypercapnic acidosis in a COPD exacerbation is treated with oxygen titrated to SpO2 88-92% and non-invasive ventilation.
- D. The acidosis is respiratory. Bicarbonate does not fix ventilation and can worsen CO2 retention.
- E. Nothing in the stem suggests opioid use. Drowsiness here is from CO2 retention.
A drowsy COPD patient with pH below 7.35 and high PaCO2 needs controlled oxygen and non-invasive ventilation if the airway is protected.
Based on: Canadian Thoracic Society COPD guidance on exacerbation management
Example 5
A 61-year-old woman sees her family physician for a periodic health review. She smoked about 1 pack a day from age 20 until she quit at age 53, a history of roughly 33 pack-years. She has no cough, hemoptysis or weight loss and is otherwise well. Her lung examination is normal. She asks what cancer screening she should have for her lungs.
Which recommendation is most appropriate?
-
Chest X-ray does not reduce lung cancer deaths and is not a screening test.
-
She is 55 to 74, has at least 30 pack-years and quit less than 15 years ago, so she meets CTFPHC criteria for annual low-dose CT for up to three years.
-
Quitting under 15 years ago does not remove eligibility under CTFPHC criteria.
-
Sputum cytology is not recommended for lung cancer screening.
-
A diagnostic contrast CT gives more radiation and is not the screening test; screening uses low-dose CT.
Show answer and reasoning
Answer: B. Low-dose CT yearly for up to 3 years
- A. Chest X-ray does not reduce lung cancer deaths and is not a screening test.
- B. She is 55 to 74, has at least 30 pack-years and quit less than 15 years ago, so she meets CTFPHC criteria for annual low-dose CT for up to three years.
- C. Quitting under 15 years ago does not remove eligibility under CTFPHC criteria.
- D. Sputum cytology is not recommended for lung cancer screening.
- E. A diagnostic contrast CT gives more radiation and is not the screening test; screening uses low-dose CT.
Know the CTFPHC rule: 55-74 years, 30+ pack-years, current or quit under 15 years, low-dose CT yearly for up to 3 years.
Based on: Canadian Task Force on Preventive Health Care lung cancer screening recommendation
Quick recall
Tap a card to turn it over. If you can answer all of them without looking, move on to timed questions.
Where candidates lose marks
- Stepping up without checking technique
Before adding drugs for poorly controlled asthma or COPD, check inhaler technique, adherence and triggers.
- Using US lung screening rules
CTFPHC criteria are age 55-74 and 30 pack-years. US criteria are broader and give a different answer.
- Applying PERC to a patient on estrogen
Any failed PERC item means PERC cannot rule out PE. Go to D-dimer if probability is low.
- High-flow oxygen in CO2 retainers
In hypercapnic COPD, titrate oxygen to SpO2 88-92% to avoid worsening respiratory acidosis.
- Steroids for IPF
Idiopathic pulmonary fibrosis is treated with antifibrotics, supportive care and transplant referral, not long-term steroids.
How to study respirology
Read the MCC Objectives for dyspnea, cough, wheezing, hemoptysis and abnormal chest imaging, and list the decisions each one tests.
Learn the CTS asthma and COPD treatment steps and the CTFPHC lung screening criteria from memory.
Practise 20 blood gas and 10 pleural fluid interpretations with full calculations.
Do 40 timed respirology questions in this question bank and review the reasoning for every option.
Make a single sheet comparing Canadian and US recommendations for screening, inhaler choice and antibiotics.
Finish with mixed medicine blocks so you learn to spot PE, TB and heart failure hidden in respiratory presentations.
Sources and further reading
Check the current edition of each guideline before your exam. This page is study material, not clinical advice.
- Medical Council of Canada: MCC Examination Objectives
- Canadian Thoracic Society: clinical practice guidelines (asthma, COPD, sleep)
- Canadian Task Force on Preventive Health Care: lung cancer screening
- Canadian Tuberculosis Standards (Public Health Agency of Canada)
- Canadian Immunization Guide (NACI)
- Thrombosis Canada clinical guides
- Choosing Wisely Canada